A robotic tray-loading system from ESS Technologies gently handles glass prefilled syringes.
Courtesy ESS Technologies.
ESS Technologies, an authorized system integrator for FANUC America, has designed a robotic tray-loading system that gently handles glass prefilled syringes. The high-speed pick-and-place system integrates three FANUC LR Mate 200iD robots with ESS-designed end-of-arm tooling (EOAT) to automate loading five-count thermoformed trays at a rate of up to 25 trays per minute.
The operator manually loads thermoformed trays into high-capacity tray magazines. Syringes enter the starwheel infeed via an infeed track that connects to the syringe-filling equipment at a rate of 125 syringes per minute. A starwheel picks syringes and lays them in carriers on the infeed conveyor. The first FANUC robot uses vacuum EOAT to pick a tray and, with the help of line tracking, places it on the lugged tray transport conveyor. A second robot, also equipped with line tracking, picks five syringes from the syringe infeed conveyor, loads three in the tray, and rotates the remaining two syringes 180-degrees before placing them to complete the tray. Any missed syringes fall into a soft discharge bin to be manually re-introduced into the robotic tray-loading cell.
Loaded trays convey to a tamping station that gently presses all five syringes into their locking cavities. At the discharge, a third FANUC robot uses a hybrid vacuum/gripper EOAT to rotate a tray and stack it on the tray that follows. The robot then picks both trays and places them on a discharge conveyor for downstream inspection and cartoning.
Source: ESS Technologies
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of On-Demand Manufacturing and Derisking in Accelerating Early Clinical Trial Success
June 4th 2025Small pharmaceutical companies are constantly seeking innovative solutions to streamline early clinical trials. Adaptive clinical trials offer important benefits to sponsors and patients, both from a commercial and ethical standpoint. These trials offer flexibility and efficiency, especially in the early stages, where trial protocols can be adjusted based on interim data, such as introducing new doses or modifying participant sample size. However, adjusting manufacturing demand during an adaptive trial can be complicated, and strict regulatory requirements present significant challenges. On-demand manufacturing provides a robust solution, allowing for real-time supply and demand adjustments and improved trial flexibility. This paper explores how on-demand manufacturing meets the operational needs of adaptive trials and aligns with regulatory expectations.